Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques

BACKGROUND: Neoadjuvant chemotherapy (NACT) is widely used as an efficient breast cancer treatment. Ideally, a pathological complete response (pCR) can be achieved. Up to date, there is no reliable way of predicting a pCR. For the first time, we explore the ability of minimal invasive biopsy (MIB) t...

Descripción completa

Detalles Bibliográficos
Autores principales: Heil, Joerg, Kümmel, Sherko, Schaefgen, Benedikt, Paepke, Stefan, Thomssen, Christoph, Rauch, Geraldine, Ataseven, Beyhan, Große, Regina, Dreesmann, Volker, Kühn, Thorsten, Loibl, Sibylle, Blohmer, Jens-Uwe, von Minckwitz, Gunter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705891/
https://www.ncbi.nlm.nih.gov/pubmed/26554654
http://dx.doi.org/10.1038/bjc.2015.381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705891/
https://www.ncbi.nlm.nih.gov/pubmed/26554654
http://dx.doi.org/10.1038/bjc.2015.381

Ejemplares similares